Familial hypoparathyroidism
Gene: CASREnsemblGeneIds (GRCh38): ENSG00000036828
EnsemblGeneIds (GRCh37): ENSG00000036828
OMIM: 601199, Gene2Phenotype
CASR is in 13 panels
3 reviews
Ivone Leong (Genomics England Curator)
As discussed in the GMS Endocrinology Specialist Test Group webex call 28th Jan 2019: The Specialist Test Group agreed that there is enough evidence to rate this gene green.Created: 5 Feb 2019, 2:37 p.m.
Sarah Leigh (Genomics England Curator)
Comment when marking as ready: Associated with phenotype in OMIM, not in G2P. Found in 2/4 sources. One reviewer recommends Green. Current diagnosticCreated: 3 Jun 2016, 2:38 p.m.
Comment on mode of pathogenicity: ADH1 caused by GOF mutations in CASR, LOF cause FHH1/FIHP/NHPTCreated: 3 Jun 2016, 2:21 p.m.
Treena Cranston (Oxford)
ADH1 caused by GOF mutations in CASR, LOF cause FHH1/FIHP/NHPTCreated: 13 Oct 2015, 11:23 a.m.
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
ADH1
Mode of pathogenicity
Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments
Variants in this GENE are reported as part of current diagnostic practice
Details
- Mode of Inheritance
- BOTH monoallelic and biallelic, autosomal or pseudoautosomal
- Sources
-
- Expert Review Green
- Eligibility statement prior genetic testing
- Expert list
- UKGTN
- Illumina TruGenome Clinical Sequencing Services
- Phenotypes
-
- Hyperparathyroidism, neonatal, 239200
- Hypocalcemia, autosomal dominant, with or without Bartter syndrome, 601198
- OMIM
- 601199
- Clinvar variants
- Variants in CASR
- Penetrance
- Complete
- Mode of Pathogenicity
- Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments
- Panels with this gene
-
- Calcium-sensing receptor phenotypes
- Nephrocalcinosis or nephrolithiasis
- Early onset or syndromic epilepsy
- Familial pulmonary fibrosis
- Renal tubulopathies
- Parathyroid Cancer
- Intellectual disability
- Fetal anomalies
- Familial hyperparathyroidism or hypocalciuric hypercalcaemia
- Skeletal dysplasia
- Osteogenesis imperfecta
- Familial hypoparathyroidism
- Pancreatitis
History Filter Activity
Gene classified by Genomics England curator
Sarah Leigh (Genomics England Curator)This gene has been classified as Green List (High Evidence).
Gene classified by Genomics England curator
Sarah Leigh (Genomics England Curator)This gene has been classified as Green List (High Evidence).
Set Phenotypes
Sarah Leigh (Genomics England Curator)Phenotypes for CASR were set to Hyperparathyroidism, neonatal, 239200; Hypocalcemia, autosomal dominant, with or without Bartter syndrome, 601198
Set Mode of Inheritance
Sarah Leigh (Genomics England Curator)Mode of inheritance for CASR was changed to BOTH monoallelic and biallelic, autosomal or pseudoautosomal
Set Phenotypes
Sarah Leigh (Genomics England Curator)Phenotypes for gene CASR were set to Hyperparathyroidism, neonatal, 239200; Hypocalcemia, autosomal dominant, with and without Bartter syndrome, 601198
Set mode of pathogenicity
Sarah Leigh (Genomics England Curator)Mode of pathogenicity for CASR was changed to Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments
Set Phenotypes
Sarah Leigh (Genomics England Curator)Phenotypes for gene CASR were set to Familial Isolated Hypoparathyroidism;Hypoparathyroidism, Familial Isolated
Added New Source
Ellen McDonagh (Genomics England Curator)CASR was added to Familial or syndromic hypoparathyroidismpanel. Sources: Eligibility statement prior genetic testing
Added New Source
Eik Haraldsdottir (Genomics England)CASR was added to Familial or syndromic hypoparathyroidismpanel. Sources: Expert list
Added New Source
Eik Haraldsdottir (Genomics England)CASR was added to Familial or syndromic hypoparathyroidismpanel. Sources: UKGTN
Added New Source
Eik Haraldsdottir (Genomics England)CASR was added to Familial or syndromic hypoparathyroidismpanel. Sources: Illumina TruGenome Clinical Sequencing Services